Bristol-Myers Squibb sell Morgan Stanley
Start price
27.10.23
/
50%
€49.80
Target price
27.10.24
€47.31
Performance (%)
-15.13%
Price
30.04.24
€41.17
Summary
This prediction is currently active. The price of Bristol-Myers Squibb has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.13%. A total of €1.10 was paid as dividends for this prediction. This prediction currently runs until 27.10.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | -9.864% | -9.864% |
| iShares Core DAX® | -0.992% | -3.231% |
| iShares Nasdaq 100 | -0.225% | -3.339% |
| iShares Nikkei 225® | -0.736% | -7.859% |
| iShares S&P 500 | -0.509% | -2.979% |
Comments by Morgan_Stanley for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its price target lowered by analysts at Morgan Stanley from $56.00 to $50.00. They now have an "underweight" rating on the stock.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Morgan_Stanley for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€53.40
11.10.23
11.10.23
€52.70
11.10.24
11.10.24
-20.85%
30.04.24
30.04.24
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.70
19.07.23
19.07.23
€52.70
19.07.24
19.07.24
-23.15%
30.04.24
30.04.24